Stock listing
NASDAQ:CVKD Cadrenal Therapeutics, Inc. Stock
Home listing (NASDAQ) of Cadrenal Therapeutics, Inc.
Follow Cadrenal Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:CVKD
$0.985 USD +0.042 (+4.4%)
Close on Oct 30, 2026
- Day range
- $0.940 – $1.000 USDOct 30, 2026
- Volume
- 80,670 sharesOct 30, 2026
- Market cap
- $3.51M USDAt the close on Oct 30, 2026 · price × 3.57M shares outstanding
- 52-week range
- $0.816 – $13.750 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $723,075 USDMedian day 60,190 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CVKD · Home | $0.985 USD | +0.042 (+4.4%) | 80,670 | $0.940 | $1.000 | $0.940 | $0.943 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:CVKD · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.985 | +0.042 | +4.4% | $0.940 | $1.000 | $0.940 | 80,670 | |
| $0.943 | -0.004 | -0.5% | $1.000 | $1.000 | $0.940 | 44,027 | |
| $0.948 | +0.006 | +0.6% | $0.946 | $0.981 | $0.912 | 37,452 | |
| $0.942 | +0.032 | +3.5% | $0.900 | $0.990 | $0.860 | 60,380 | |
| $0.910 | -0.050 | -5.2% | $0.960 | $0.960 | $0.910 | 52,210 | |
| $0.960 | -0.010 | -1.0% | $0.965 | $1.000 | $0.930 | 38,200 | |
| $0.970 | -0.050 | -4.9% | $1.030 | $1.070 | $0.960 | 19,800 | |
| $1.020 | -0.020 | -1.9% | $1.020 | $1.030 | $1.000 | 28,200 | |
| $1.040 | -0.020 | -1.9% | $1.040 | $1.100 | $1.000 | 48,700 | |
| $1.060 | -0.030 | -2.8% | $1.060 | $1.100 | $0.998 | 152,200 | |
| $1.090 | +0.120 | +12.4% | $0.960 | $1.120 | $0.960 | 173,200 | |
| $0.970 | -0.050 | -4.9% | $0.990 | $1.030 | $0.965 | 104,200 | |
| $1.020 | +0.023 | +2.3% | $0.930 | $1.100 | $0.920 | 344,300 | |
| $0.997 | +0.125 | +14.3% | $0.889 | $1.060 | $0.874 | 376,400 | |
| $0.872 | -0.038 | -4.2% | $0.918 | $0.918 | $0.816 | 111,400 | |
| $0.910 | -0.020 | -2.2% | $0.974 | $0.974 | $0.900 | 82,400 | |
| $0.930 | -0.042 | -4.3% | $0.994 | $0.994 | $0.870 | 311,200 | |
| $0.972 | -0.018 | -1.8% | $1.010 | $1.070 | $0.917 | 1,781,700 | |
| $0.990 | +0.044 | +4.7% | $0.943 | $1.050 | $0.900 | 98,000 | |
| $0.946 | +0.006 | +0.6% | $0.970 | $1.000 | $0.935 | 63,000 | |
| $0.940 | -0.030 | -3.1% | $0.980 | $1.005 | $0.850 | 149,600 | |
| $0.970 | -0.110 | -10.2% | $1.090 | $1.090 | $0.970 | 109,200 | |
| $1.080 | -0.010 | -0.9% | $1.100 | $1.100 | $1.050 | 21,700 | |
| $1.090 | -0.030 | -2.7% | $1.100 | $1.130 | $1.080 | 38,200 | |
| $1.120 | -0.030 | -2.6% | $1.160 | $1.160 | $1.070 | 75,600 | |
| $1.150 | -0.050 | -4.2% | $1.250 | $1.250 | $1.130 | 224,700 | |
| $1.200 | -0.120 | -9.1% | $1.310 | $1.355 | $1.190 | 119,000 | |
| $1.320 | +0.200 | +17.9% | $1.120 | $1.348 | $1.060 | 269,000 | |
| $1.120 | +0.030 | +2.8% | $1.110 | $1.139 | $1.060 | 73,500 | |
| $1.090 | +0.020 | +1.9% | $1.070 | $1.110 | $1.060 | 66,800 | |
| $1.070 | -0.050 | -4.5% | $1.120 | $1.160 | $1.070 | 113,600 | |
| $1.120 | +0.040 | +3.7% | $1.100 | $1.140 | $1.080 | 44,900 | |
| $1.080 | +0.030 | +2.9% | $1.050 | $1.100 | $1.010 | 55,600 | |
| $1.050 | -0.010 | -0.9% | $1.060 | $1.120 | $1.040 | 56,400 | |
| $1.060 | -0.030 | -2.8% | $1.070 | $1.100 | $1.054 | 47,600 | |
| $1.090 | -0.090 | -7.6% | $1.170 | $1.189 | $1.000 | 228,600 | |
| $1.180 | -0.010 | -0.8% | $1.170 | $1.200 | $1.140 | 119,800 | |
| $1.190 | -0.010 | -0.8% | $1.220 | $1.230 | $1.140 | 114,600 | |
| $1.200 | -0.020 | -1.6% | $1.200 | $1.260 | $1.160 | 161,800 | |
| $1.220 | -0.060 | -4.7% | $1.260 | $1.295 | $1.200 | 177,400 | |
| $1.280 | -0.050 | -3.8% | $1.340 | $1.410 | $1.270 | 168,600 | |
| $1.330 | -0.180 | -11.9% | $1.400 | $1.530 | $1.280 | 388,300 | |
| $1.510 | -0.240 | -13.7% | $1.490 | $1.580 | $1.420 | 783,800 | |
| $1.750 | +0.210 | +13.6% | $1.640 | $2.290 | $1.460 | 21,599,200 | |
| $1.540 | -0.025 | -1.6% | $1.560 | $1.600 | $1.500 | 31,100 | |
| $1.565 | +0.015 | +1.0% | $1.520 | $1.622 | $1.520 | 48,200 | |
| $1.550 | +0.020 | +1.3% | $1.560 | $1.643 | $1.490 | 24,700 | |
| $1.530 | -0.040 | -2.5% | $1.560 | $1.610 | $1.500 | 39,200 | |
| $1.570 | -0.040 | -2.5% | $1.690 | $1.690 | $1.540 | 36,200 | |
| $1.610 | +0.020 | +1.3% | $1.620 | $1.620 | $1.541 | 36,200 | |
| $1.590 | -0.050 | -3.0% | $1.650 | $1.725 | $1.580 | 60,000 | |
| $1.640 | -0.070 | -4.1% | $1.750 | $1.775 | $1.620 | 81,000 | |
| $1.710 | -0.050 | -2.8% | $1.760 | $1.820 | $1.640 | 59,400 | |
| $1.760 | -0.110 | -5.9% | $1.880 | $1.880 | $1.710 | 37,200 | |
| $1.870 | +0.010 | +0.5% | $1.880 | $1.914 | $1.790 | 27,900 | |
| $1.860 | +0.020 | +1.1% | $1.850 | $1.969 | $1.760 | 35,900 | |
| $1.840 | -0.100 | -5.2% | $1.945 | $1.980 | $1.770 | 63,600 | |
| $1.940 | 0.000 | 0.0% | $1.975 | $2.120 | $1.920 | 46,300 | |
| $1.940 | -0.010 | -0.5% | $1.960 | $2.013 | $1.910 | 20,000 | |
| $1.950 | +0.080 | +4.3% | $1.900 | $2.050 | $1.870 | 30,100 | |
| $1.870 | -0.090 | -4.6% | $1.980 | $1.991 | $1.870 | 25,700 | |
| $1.960 | -0.070 | -3.4% | $2.070 | $2.100 | $1.900 | 33,000 | |
| $2.030 | +0.070 | +3.6% | $1.960 | $2.170 | $1.960 | 40,700 | |
| $1.960 | -0.050 | -2.5% | $1.970 | $2.160 | $1.900 | 40,900 | |
| $2.010 | -0.080 | -3.8% | $2.080 | $2.110 | $1.970 | 14,900 | |
| $2.090 | +0.120 | +6.1% | $2.010 | $2.090 | $1.961 | 17,800 |
- Ticker
- NASDAQ:CVKD
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 7, 2026
Cadrenal Therapeutics Retains Tungsten Advisors to Lead Formal Strategic Process to Maximize Value of its Orphan Thrombo-Inflammatory Therapeutics
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 21 slides
Latest news
Cadrenal Therapeutics Retains Tungsten Advisors to Lead Formal Strategic Process to Maximize Value of its Orphan Thrombo-Inflammatory Therapeutics
Oct 7, 2026
Closed $0.972 (-1.8%) on Oct 7, 2026
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2026 Investor Conference
Sep 21, 2026
Closed $1.12 (+2.8%) on Sep 22, 2026
Cadrenal Therapeutics to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
Sep 3, 2026
Closed $1.28 (-3.8%) on Sep 3, 2026
Cadrenal Therapeutics Announces Positive Outcome from FDA Type D Meeting for Phase 3 Registration Study of CAD-1005 in Heparin-Induced Thrombocytopenia
Aug 31, 2026
Closed $1.75 (+13.6%) on Aug 31, 2026
Cadrenal Therapeutics Reports Second Quarter 2026 Financial Results; Provides a Corporate Update on the Cardiac Acute Critical Care Franchise and the Strategic Partnering Process
Aug 13, 2026
Closed $1.87 (+0.5%) on Aug 14, 2026
Cadrenal Therapeutics Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation
Jul 21, 2026
Closed $2.17 (+3.8%) on Jul 21, 2026
Cadrenal Therapeutics’ Late-Breaking Phase 2 Data Demonstrate Greater Than 25% Reduction in Thrombotic Events in HIT for First-in-Class 12-LOX Inhibitor CAD-1005 at ISTH 2026 Congress
Jul 13, 2026
Closed $2.42 (-16.3%) on Jul 13, 2026
Cadrenal Therapeutics Announces up to $8.8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Jun 30, 2026
Closed $3.17 (-5.1%) on Jul 1, 2026
Cadrenal Therapeutics Announces Selection of CAD-1005 Phase 2 Study for Late-Breaking Oral Presentation at ISTH 2026 Congress
Jun 24, 2026
Closed $2.98 (-2.6%) on Jun 24, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 21 slides · September 2026
Investor Presentation (May 2026)
Investor deck · 18 slides · May 2026
Investor Presentation (December 2025)
Investor deck · 23 slides · Dec 11, 2025
Investor Presentation (September 2025)
Investor deck · 26 slides · Sep 15, 2025
Cadrenal Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 27 in the last 12 months · 92 in all · newest Oct 7, 2026 · oldest 2023
- Decks
- 14 decks · latest September 2026
Where Cadrenal Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CVKD · Home listing · This page | NASDAQ | United States | USD |
| BOATS:CVKD | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Cadrenal Therapeutics, Inc.